CANCER diagnosis and treatment could be "revolutionised" by a new low-cost blood test that allows doctors to track genetic changes in tumour cells, researchers claim.
The "liquid biopsy" test identifies defective fragments of DNA shed into the bloodstream by cancer cells as they die.
Scientists have already used it to detect genetic faults involved in tumour growth in blood samples from 20 women with ovarian cancer.
We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis. If you're a relatively new user then your comments will be reviewed before publication and if we know you well then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules, which are available here.
Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.
